Viridian (VRDN) news
Recent news
Viridian Therapeutics Q2 revenue USD 284 thousand vs. IBES estimate USD 22.3 thousand
AInvest Wire · Aug 6, 2026Viridian Therapeutics highlights recent business progress and reports second quarter 2026 financial results
AInvest Wire · Aug 6, 2026Viridian SA - geo backlog of $306M at end-June 2026, up +19% vs end-December 2025
AInvest Wire · Jul 30, 2026Viridian 2Q segment revenue $232M
Viridian Therapeutics reported segment revenue of $232 million for the second quarter of 2026, reflecting continued progress in its clinical development and licensing initiatives. The company’s revenue primarily stems from collaboration agreements and licensing deals, including its partnership with…
AInvest Wire · Jul 30, 2026Viridian Metals announces results of annual general and special meeting and closing of non-brokered private placement
Viridian Metals Inc. (CSE: VRDN) has announced the successful closing of its Annual General and Special Meeting (AGM) held on June 22, 2026, and the completion of a non-brokered private placement. The AGM was conducted in person at the offices of the Company’s counsel in Vancouver, British…
AInvest Wire · Jul 7, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.